The SMAC mimetic, LCL-161, reduces survival in aggressive MYC-driven lymphoma while promoting susceptibility to endotoxic shock. [electronic resource]
Producer: 20160405Description: e216 p. digitalISSN:- 2157-9024
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.